Effects of Hysteroscopic Electroendometrial Resection Combined with Levonorgestrel Intrauterine Birth Control System on Endometrial Thickness, Sex Hormone Levels and AUB Recurrence Rate in Perimenopausal AUB Patients
TIAN Xingfang, YANG Ziping
Department of Gynaecology and Obstetrics, Anting Hospital in Shanghai's Jiading District,Shanghai 201805
Abstract：【Objective】To investigate the effects of hysteroscopic electroendometrial resection combined with levonorgestrel intrauterine birth control system on endometrial thickness, sex hormone levels and recurrence rate in patients with perimenopausal abnormal uterine bleeding (AUB). 【Methods】A total of 90 patients with perimenopausal AUB admitted to our hospital from February 2020 to March 2023 were selected and divided into the observation group (n=46) and the control group (n=44) by random envelope method. The control group was treated with hysteroscopic electrohysterectomy, while the observation group was treated with levonorgestrel intrauterine birth control system combined with hysteroscopic electrohysterectomy. The therapeutic effect, menstrual blood loss chart (PBAC) score, endometrial thickness, hemoglobin (Hb), sex hormone level, complications, menstrual status, and recurrence of the two groups were compared. 【Results】The total effective rate of the observation group was 95.65%, which was significantly higher than that of the control group (81.82%, P<0.05). After treatment, the PBAC score and endometrial thickness of both groups decreased with the observation group showing lower than the control group (P<0.05). After treatment, Hb increased in both groups, and Hb in the observation group was higher than that in the control group (P<0.05). After treatment, estradiol (E2), progesterone (P), follicle stimulating hormone (FSH) and luteinizing hormone (LH) decreased in both groups, while E2,P,FSH and LH levels in the observation group were lower than those in the control group (P<0.05). After 6 months of treatment, there was no significant difference in the incidence of infection, uterine adenomyosis and tubal sterilization syndrome between the two groups (P>0.05). The incidence of uterine adhesion in the observation group was lower than that in the control group (P<0.05). There was no significant difference in amenorrhea and normal menses between the two groups(P>0.05). The decrease rate of menstrual volume in observation group was higher than that in control group (P<0.05). The recurrence rate of bleeding in observation group was lower than that in control group (P<0.05). 【Conclusion】Hysteroscopic electroendometrial resection combined with levonorgestrel intrauterine birth control system is effective in the treatment of patients with abnormal uterine bleeding in perimenopausal period, which can reduce the amount of blood loss, sex hormone level and endometrial thickness. It has good safety and low recurrence rate.
田兴芳, 杨自萍. 宫腔镜子宫内膜电切除术联合左炔诺孕酮宫内节育系统治疗围绝经期AUB患者对子宫内膜厚度、性激素水平及AUB复发率的影响[J]. 医学临床研究, 2024, 41(4): 492-495.
TIAN Xingfang, YANG Ziping. Effects of Hysteroscopic Electroendometrial Resection Combined with Levonorgestrel Intrauterine Birth Control System on Endometrial Thickness, Sex Hormone Levels and AUB Recurrence Rate in Perimenopausal AUB Patients. JOURNAL OF CLINICAL RESEARCH, 2024, 41(4): 492-495.
[1] VITALE S G, WATROWSKI R, BARRA F,et al. Abnormal uterine bleeding in perimenopausal women: the role of hysteroscopy and its impact on quality of life and sexuality[J].Diagnostics (Basel),2022,12(5):1176. [2] CHAPAGAIN S, DANGAL G. Clinical and histopathological presentation of abnormal uterine bleeding in perimenopausal women in tertiary center of nepal[J].J Nepal Health Res Counc,2020,18(2): 248-252. [3] SHANG Y J, LU S, CHEN Y, et al. Chinese herbal medicines for the treatment of non-structural abnormal uterine bleeding in perimenopause: A systematic review and a meta-analysis[J].Complement Ther Med,2018,41: 252-260. [4] 王欣, 于婷, 杨惠娟, 等. 围绝经期异常子宫出血的治疗进展[J].医学综述, 2021,27(3): 540-544. [5] 宗云, 刘金星. 中西医治疗围绝经期异常子宫出血研究进展[J].海南医学院学报, 2021,27(6): 472-476. [6] HELLELAND L, BERGESEN L F, RINNAN K J, et al. Endometrial ablation: less is more? Historical cohort study comparing long-term outcomes from two time periods and two treatment modalities for 854 women[J].PLoS One,2019,14(7): e219294. [7] WORTMAN M. Endometrial ablation: past, present, and future part Ⅱ[J].Surg Technol Int,2018,33: 161-177. [8] MITTERMEIER T, FARRANT C, WISE M R. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia[J].Cochrane Database Syst Rev,2020,9(9): CD12658. [9] EVRUKE I, TAS I S. Operative hysteroscopy versus levonorgestrel-releasing intrauterine system (LNG-IUS) insertion: a prospective observational study on the effect of surgical and medical treatments on sexual functions in women with abnormal uterine bleeding[J].Cureus,2023,15(3): e36035. [10] 中华医学会妇产科学分会妇科内分泌学组. 异常子宫出血诊断与治疗指南[J].中华妇产科杂志,2014,49(11):801-806. [11] NAGAO A, TOKUGAWA T, MATSUO Y, et al. The length of the sanitary napkins can be used as a handier index than pictorial blood loss assessment chart to predict the heavy menstrual bleeding[J].J Obstet Gynaecol Res,2023,49(7): 1838-1845. [12] PAPAKONSTANTINOU E, ADONAKIS G. Management of pre-, peri-, and post-menopausal abnormal uterine bleeding: when to perform endometrial sampling?[J].Int J Gynaecol Obstet,2022,158(2): 252-259. [13] LOUIE M Y, VEGUNTA S. Abnormal uterine bleeding in perimenopausal women[J].J Womens Health (Larchmt),2022,31(8): 1084-1086. [14] JEWSON M, PUROHIT P, LUMSDEN M A. Progesterone and abnormal uterine bleeding/menstrual disorders[J].Best Pract Res Clin Obstet Gynaecol,2020,69: 62-73. [15] TROÌA L, MARTONE S, MORGANTE G, et al. Management of perimenopause disorders: hormonal treatment[J].Gynecol Endocrinol,2021,37(3): 195-200. [16] SAHU H D, VARMA A V, KARMARKAR S, et al. Endometrial histopathology in abnormal uterine bleeding and its relation with thyroid profile and endometrial thickness[J].Cureus,2023,15(4): e37931. [17] 蒋英敏, 王荣妹. 宫腔镜电切术分别联合地屈孕酮与曼月乐治疗围绝经期异常子宫出血的临床效果研究[J].实用妇科内分泌电子杂志, 2021,8(3): 1-4. [18] 杨梅, 杨华, 王彤. 宫腔镜电切术联合曼月乐治疗子宫内膜息肉疗效及对患者雌孕激素受体表达和炎症因子的影响[J].中国计划生育学杂志, 2023,31(1): 60-63. [19] BOFILL R M, LETHABY A, JORDAN V. Progestogen-releasing intrauterine systems for heavy menstrual bleeding[J].Cochrane Database Syst Rev,2020,6(6): CD2126. [20] 沈育红, 刘延, 龙雯晴. 左炔诺孕酮宫内节育系统联合宫腔镜子宫内膜电切术治疗围绝经期异常子宫出血的临床疗效及安全性评价[J].临床和实验医学杂志, 2021,20(2): 197-200.
2024, Vol. 41 
